...
机译:肾脏移植成果来自较旧的已故捐赠者:由欧洲肾协联合 - 欧洲透析和移植协会登记处的配对肾分析
Department of Medical InformaticsERA‐EDTA RegistryAmsterdam the Netherlands;
Department of Medical InformaticsERA‐EDTA RegistryAmsterdam the Netherlands;
UK Renal RegistrySouthmead HospitalBristol UK;
UK Renal RegistrySouthmead HospitalBristol UK;
Department of Transplantation SurgeryKarolinska University HospitalStockholm Sweden;
Department of NephrologyHelsinki University Central HospitalHelsinki Finland;
Department of MedicineRoskilde HospitalRoskilde Denmark;
Section for Clinical BiometricsMedical University of ViennaVienna Austria;
Dutch Transplant FoundationLeiden the Netherlands;
Austrian Dialysis &
Transplant RegistryRohr Austria;
Department of Transplantation and Liver SurgeryHelsinki University HospitalHelsinki Finland;
Unidad de Información sobre Pacientes Renales de la Comunidad Autónoma del País Vasco (UNIPAR;
Department of Transplant MedicineOslo University HospitalRikshospitalet Oslo Norway;
Statistics and Clinical StudiesNHS Blood and TransplantStoke Gifford Bristol UK;
Department of NephrologyHospital del MarBarcelona Spain;
Swedish Renal RegistryMedicinexp J?nk?ping Sweden;
Department of Nephrology PRigshospitaletCopenhagen Denmark;
Scottish Renal RegistryISD ScotlandGlasgow Scotland;
Division of NephrologyAmbroise Paré University HospitalBoulogne‐Billancourt France;
Richard Bright Renal UnitSouthmead HospitalBristol UK;
Department of Medical InformaticsERA‐EDTA RegistryAmsterdam the Netherlands;
deceased donors; donor age; graft survival; kidney transplant; registry;
机译:肾脏移植成果来自较旧的已故捐赠者:由欧洲肾协联合 - 欧洲透析和移植协会登记处的配对肾分析
机译:欧洲成年人的肾移植获得75-84岁及相关结果:欧洲肾协协理 - 欧洲透析和移植协会登记处的分析
机译:儿童,青少年和年轻成年人获得和移植肾脏的种族差异:ESPN / ERA-EDTA(欧洲儿科肾脏病学会/欧洲肾脏协会-欧洲透析和移植协会)注册结果
机译:使用顺序活体供体肾和自体干细胞移植患者对原发性(Al)淀粉样蛋白病和晚期肾功能衰竭的患者
机译:肾移植结果的回顾性分析:死者和活体供者肾脏移植患者中抗胸腺细胞球蛋白与Alemtuzumab的诱导免疫抑制作用。
机译:肾脏替代疗法在世界上两个不同地区的流行病学:拉丁美洲透析和移植注册中心与欧洲肾脏协会-欧洲透析和移植协会注册中心
机译:欧洲死者肾脏和肾移植成果质量的时间趋势:ERA-EDTA登记处的分析